儿童肝炎C查通过孕妇肝炎C感染状态在怀孕期间的查
Julia DiNicola1, Anthony Lentscher1, Hui Liu2
1University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Journal of the Pediatric Infectious Diseases Society
|June 25, 2024
概括
儿童肝炎C病毒 (HCV) 查水平较低. 出生于活跃HCV感染的母亲的婴儿更有可能接受查,但许多婴儿仍未被检测到. 较早的查指南可能会提高率.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 儿童传染病 儿童传染病
- 公共卫生 公共卫生
背景情况:
- 婴儿的周产期肝炎C病毒 (HCV) 查率仍然低于最佳水平.
- 与怀孕期间母亲的HCV感染状况相关的儿科查实践尚未得到充分理解.
研究的目的:
- 调查怀孕期间母亲的HCV感染状况与儿科HCV查的可能性之间的联系.
- 确定影响儿科HCV查完成的因素.
主要方法:
- 对2015-2019年间出生的母婴对进行了回顾性队列研究.
- 根据RNA检测,母亲的HCV感染被分类为活跃,可能或以前的.
- 逻辑回归用于根据母亲的HCV状况确定婴儿查的几率比率 (OR).
主要成果:
- 婴儿查完成程度因母亲的感染状况而异 (43%以前,49%可能,58%活跃).
- 活跃HCV感染的母亲的婴儿与以前感染的婴儿相比,查的可能性是2.5倍.
- 查测试的订购与母亲吸烟,晚年访问年龄和记录的HCV暴露有关;完成与非生物父母和早期出生年相关.
结论:
- 出生于活跃HCV感染的母亲的婴儿的查率更高,但许多婴儿仍未接受查,导致未被检测到的儿科HCV感染.
- 目前的查实践不足以捕捉所有有风险的婴儿.
- 针对早期儿科HCV查的最新CDC指南可能会提高检测率.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Metabolism
410
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Pediatric Patients: Drug Excretion
408
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Cytomegalovirus Disease
102
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
102
Hepatitis
86
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Viral Hepatitis I: Introduction
25
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
25


